NGM313, a Novel Activator of β-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects

ngm313-a-novel-activator-of-%CE%B2-klotho-fgfr1c-improves-insulin-resistance-and-reduces-hepatic-fat-in-obese-nondiabetic-subjects